European Journal of Neurology

Article	Citations
	118
	98
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	92
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	91
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	90
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	89
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	78
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	73
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	68
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	66
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	60
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	57
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	57
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities	57
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	56
Mirror therapy for unilateral neglect after stroke: A systematic review	55
Issue Information	54
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	50
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	50
Central nervous system crystal‐storing histiocytosis: A case report and literature review	48
ePoster	46
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis	45
Neuropathy in GAA‐FGF14 Late‐Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics	45
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	44
Lessons from the past to understand the future	44

Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	44
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	44
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	42
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	42
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	42
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	41
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	41
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	41
Long‐term MRI changes in a patient with Kelch‐like protein 11‐associated paraneoplastic neurological syndrome	41
Comparative features and outcomes of major neurological complications of COVID‐19	40
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy	40
Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population‐based comparison with mild cognitive impairment	40
Prioritization process for European Academy of Neurology clinical practice guidelines	40
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	40
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	38
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	37
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	37
Oral Presentations	36
Focused Workshops	36
	36
Issue Information	36
The effect of influenza vaccination on the rate of dementia amongst older adults	36
Issue Information	36
High‐resolution magnetic resonance imaging of acute intracranial artery thrombus	35
Issue Information	35
First‐line steroid treatment for spontaneous intracranial hypotension	34
IgG4‐Related Disease Associated With Myotonic Dystrophy Type 2	34
Alterations of Fat and Ketone Body Metabolism in ALS and SMA—A Prospective Observational Study	33
Exploring the role of attention towards balance in chronic dizziness: Development of the Balance Vigilance Questionnaire	33
Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study	33
Association of symptomatic atherosclerotic carotid arteries with plaque areas showing low densities on computed tomographic angiography	33
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage	33
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease	33
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis	32
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid	32
Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study	32
Nonamyloidogenic TTR gene variants c.76G>A and c.337‐18G>C are not associated with idiopathic small‐fiber neuropathy	32
Intraepineurial Fat Fraction: A Novel MR Neurography‐Based Biomarker in Transthyretin Amyloidosis Polyneuropathy	31
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome	31
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis	31
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance	31
Dynamic Bayesian networks for stratification of disease progression in amyotrophic lateral sclerosis	30
SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection	30
A multimodal, longitudinal study of cognitive heterogeneity in early‐onset Alzheimer's disease	30
Peripheral neuropathy in ataxia‐telangiectasia: Newly characterized, has potential as a biomarker	30
Macroglossia: A potentially severe complication of late‐onset Pompe disease	29
Ipsilateral hand impairment predicts long‐term outcome in patients with subacute stroke	29
Apolipoprotein E polymorphism ε4‐stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: A prospective cohort study	29
Etiologic distribution of isolated abducens nerve palsy: Analysis of 807 patients and literature review	29
The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: An analysis of different subtypes based on high‐resolution imaging	29

Neurology Undergraduate Medical Education: A Scoping Review	28
Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals	28
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics	28
Trajectories of physical activity after ischaemic stroke: Exploring prediction of change	28
Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3	27
Nerve Conduction Study and the Prognosis of Amyotrophic Lateral Sclerosis: Exploration of Additional Neuroelectrophysiological Parameters	27
A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door‐In‐Door‐Out Times in Thrombectomy Patients: A Retrospective Analysis	27
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study	27
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea	27
Issue Information	27
Hypersomnia in anti‐glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study	27
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy	26
Corrigendum to “Tremor After Solid Organ Transplantation: Results From the TransplantLines Biobank and Cohort Study”	26
Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy	26
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis	26
Arterial Stiffness, Central Blood Pressure, and the Risk of Incident Stroke in Hypertensive Adults	26
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis	26
Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries	26
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis	26
Hyponatremia is associated with unfavorable outcomes after reperfusion treatment in acute ischemic stroke	25
‘Positive’ inter‐ictal clinical signs of functional neurological disorders are found in patients with functional dissociative seizures	25
Generative artificial intelligence in neurology: Opportunities and risks	25
Dehydration associates with lower urinary tract symptoms in progressive multiple sclerosis	25
Issue Information	25
Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease	25
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita	25
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response	25
Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study	24
ePresentations	24
Long‐term follow‐up of 64 children with classical infantile‐onset Pompe disease since 2004: A French real‐life observational study	24
Symposia	24
Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case–control study	24
Issue Information	24
Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study	23
Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology	23
Letter to the Editor in response to “Hepatitis E virus and Bell’s palsy”	23
Circulating choline pathway nutrients and depression after ischemic stroke	23
Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report	23
Double immune reconstitution therapy: Cladribine after alemtuzumab in the treatment of multiple sclerosis	23
New cellular imaging‐based method to distinguish the SPG4 subtype of hereditary spastic paraplegia	23
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status	22
Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen	22
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	22
Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight	22
Epilepsy Management in Transgender Population: More Research for Better Treatment	22
Clinical presentation and neural correlates of stroke‐associated spatial delusions	22
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database	22
Use of antihypertensive medication and formation of de novo intracranial aneurysms	22
Development of Machine‐Learning‐Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis	22
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain–gut–microbiome interactions in irritable bowel syndrome: Preliminary findings	22
Comment on “Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study”	22
Post‐COVID‐Syndrome Patients Might Overestimate Own Cognitive Impairment	22
Spontaneous intracranial hypotension — Neurological symptoms, diagnosis, and outcome	22
Mutations in alpha‐B‐crystallin cause autosomal dominant axonal Charcot–Marie–Tooth disease with congenital cataracts	22
Exercise induced muscle blood flow is decreased in Charcot–Marie–Tooth disease type 1 polyneuropathy: a power Doppler analysis	22
Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy	21
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study	21
Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients	21
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome	21
A diagnostic framework to identify vestibular involvement in multi‐sensory neurological disease	21
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?	21
Structural Alterations Associated With Cardiovascular Autonomic Failure in Multiple System Atrophy	21
Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition	21
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis	20
Prospective follow‐up study of youth and adults with onset of functional tic‐like behaviours during the COVID‐19 pandemic	20
Smartphone and custom‐made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results	20
Plenary Sessions	20
Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis	20
Data‐Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis	20
A fast and non‐invasive artificial intelligence olfactory‐like system that aids diagnosis of Parkinson's disease	20
Combined Brain‐Cardiac CT in Ischemic Stroke: Unveiling Atrial Markers Linked to Large Vessel Occlusion in AF Patients	20
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis	20
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers	20
Latency of poststroke epilepsy can predict drug resistance	20
Migraine and atrial fibrillation: a systematic review	20
The many faces of globular glial tauopathy: A clinical and imaging study	19
Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke	19
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes	19
Prolonged venous transit is associated with lower odds of excellent recovery after reperfusion in anterior large‐vessel occlusion stroke	19
Hormone therapy and disease activity in Danish women with multiple sclerosis: A population‐based cohort study	19

Quantitative proteomic analysis of cerebrospinal fluid from patients with idiopathic facial nerve palsy	19
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial	19
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis	19
Antidepressant use and stroke or mortality risk in the elderly	19
Confirmed disability progression as a marker of permanent disability in multiple sclerosis	19
Cognitive sequelae of long COVID may not be permanent: A prospective study	19
The spectrum of central nervous system involvement in Whipple's disease	19
Brain Iron Alteration in Pediatric Tourette Syndrome: A Quantitative Susceptibility Mapping Study	19
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review	19
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy	19
Quantification of muscle involvement in familial amyloid polyneuropathy using MRI	19
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample	18
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses	18
Clinical and Genetic Characterization of the Largest Cohort of Patients With D3 Limb‐Girdle Muscular Dystrophy in an Isolated Uruguayan Population	18
Association between choroid plexus volume and cognition in Parkinson disease	18
Polygenic risk of Alzheimer's disease in the Faroe Islands	18
Association of short‐term exposure to ambient air pollution with mortality from ischemic and hemorrhagic stroke	18
Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis	18
Socioeconomic status as a risk factor for motoric cognitive risk syndrome in a community‐dwelling population: A longitudinal observational study	18
Corrigendum	18
Efficiency of stroke networks for referral of mechanical thrombectomy: The more the better?	18
Optimal cut‐off value of the modified Toronto Clinical Neuropathy Score in the diagnosis of polyneuropathy	18
The Attitude towards Polypills Questionnaire (APPQ): a phase I–III development and validation study in patients with cerebrovascular disease	18
The analgesic effect of electroencephalographic neurofeedback for people with chronic pain: A systematic review and meta‐analysis	18
Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients	18
Sex differences in early‐onset Alzheimer's disease	18
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?	18
The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies	18
Corrigendum	18
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K	18
	18
Parkinson disease following COVID‐19: Report of six cases	18
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases	18
Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review	18
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization	18
Plenary Symposium	17
Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report	17
Decrement of choroid vascularization during spontaneous migraine attacks: An optical coherence tomography angiography study	17
Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan	17
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response	17
Special Sessions	17
Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID‐19	17
History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts	17
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FT	17
Peripherin: A Novel Early Diagnostic and Prognostic Plasmatic Biomarker in Amyotrophic Lateral Sclerosis	17
Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre‐ataxic spinocerebellar ataxia type 3	17
Issue Information	17
Giancarlo COMI (1947–2024)	17
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints	17
Global Health Inequalities in the Burden of Ischemic Stroke From 1990 to 2021	16
Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021	16
Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial	16
Relationship between migraine and epilepsy in a large population‐based cohort: The HUNT Study	16
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia	16
Clinical autonomic nervous system laboratories in Europe	16
The effect of head‐down tilt in experimental acute ischemic stroke	16
Symposia	16
Analysis of individual alpha frequency in a large cohort from a tertiary memory center	16
Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin Intolerance	16
Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis	16
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis	16
Cerebral Amyloid Angiopathy‐Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy	16
Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms	16
Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations	16
Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review	16
Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms	16
	16
Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study	15
Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment	15
Time‐dependent impact of type 2 diabetes mellitus on incident prodromal Alzheimer disease: A longitudinal study in 1395 participants	15
Catechol‐O‐methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease	15
	15
Symposia	15
Atrial fibrillation in young stroke patients: Associated factors and outcomes in a nationwide analysis	15
A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody‐associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis	15
Focused Workshops	15
Thank You to Our Peer Reviewers in 2024	15
Icatibant averting mechanical ventilation in acute ischemic stroke patient with alteplase‐induced orolingual angioedema	15
Clot signature in patients with large vessel occlusion stroke and concomitant active cancer	15
Nonstenotic intracranial atherosclerosis as an emerging mechanism in cryptogenic cerebral embolism	15
	15
Association of diabetes mellitus with dementia‐ and non‐dementia‐related mortality amongst women: a secondary competing risks analysis of the California Teachers Study	15
Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles	15
Long‐Term Effectiveness of Early Versus Late Microvascular Decompression for Trigeminal Neuralgia Secondary to Arterial Compression	15
Correction to “Tirofiban Benefits the Outcome of Stroke Patients With Large Artery Atherosclerosis Achieving Full Reperfusion and High NIHSS Scores”	15
Epilepsy Stands Nearby: A Pilot CT Perfusion Study on Post‐Stroke Non‐Convulsive Status Epilepticus	15
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study	15
Corneal nerve loss is related to the severity of painful diabetic neuropathy	15
	15
	15
Clinical Findings in Temporal Lobe Epilepsy Associated With Isolated Amygdala Enlargement	15
Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke	15
GGC expansions in NOTCH2NLC contribute to Parkinson disease and dopaminergic neuron degeneration	15
Suicide Risk and Associated Factors in Parkinson Disease: A Nationwide Cohort Study	15
Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease	14